SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026578
Filing Date
2021-05-11
Accepted
2021-05-11 16:28:22
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-10q_20210331.htm 10-Q 1998165
2 EX-10.1 pstx-ex101_228.htm EX-10.1 241827
3 EX-31.1 pstx-ex311_6.htm EX-31.1 17234
4 EX-31.2 pstx-ex312_7.htm EX-31.2 17210
5 EX-32.1 pstx-ex321_9.htm EX-32.1 7827
6 EX-32.2 pstx-ex322_8.htm EX-32.2 7816
  Complete submission text file 0001564590-21-026578.txt   6450132

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pstx-20210331.xml EX-101.INS 1099712
8 XBRL TAXONOMY EXTENSION SCHEMA pstx-20210331.xsd EX-101.SCH 43745
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pstx-20210331_cal.xml EX-101.CAL 45331
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pstx-20210331_def.xml EX-101.DEF 153444
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20210331_lab.xml EX-101.LAB 399409
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20210331_pre.xml EX-101.PRE 288271
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 21911694
SIC: 2836 Biological Products, (No Diagnostic Substances)